Creating brand pillars to in turn increase viewability. Driving stakeholder engagement with a goal to be CMSable. Building scrum masters and above all, be transparent. Build dark social in order to funnel users. Synchronise first party data to in turn make users into advocates.Consider outside the box thinking yet improve overall outcomes. Target sprints to... Read More
Posted by: Derek Scholes, PhD, ASHG Director of Science Policy We are delighted to announce that ASHG has a new policy platform! Developed with the help of members and approved by the Board of Directors, the platform articulates where ASHG stands on a variety of policy issues – which issues are of key importance and... Read More
Posted by: Douglas F. Dluzen, PhD, ASHG Training & Development Committee It’s fitting that the March for Science shared the spotlight with Earth Day. During the slow march down Constitution Avenue, I saw several signs sticking out from the crowd reminding the world that there is no Planet B, no other options. It was also... Read More
Trainee Author: Douglas Dluzen, PhD Postdoctoral Fellow National Institute on Aging (Photo courtesy Dr. Dluzen) Dluzen DF et al. Racial differences in microRNA and gene expression in hypertensive women. Sci Rep. 2016 Oct 25;6:35815. doi: 10.1038/srep35815. This paper emphasizes the importance of miRNA on population specific gene expression patterns. Dluzen et al. demonstrate that differential expression of a set... Read More
Contributed by TDC member Julie Jurgens May 2017 ASHG: What are some of the genetic policy items that ASHG is currently discussing? Dr. Scholes: The Preserving Employee Wellness Programs Act (HR1313) is currently a major focus. This legislation, recently introduced in the U.S. Congress, would eviscerate key genetic privacy protections in the Genetic Information Nondiscrimination Act (GINA). GINA prevents employers... Read More
ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy